BioXcel Therapeutics

BTAINASDAQ
$1.08
-0.04-3.57%
At Close: -
$1.09
0.010.93%
After Hours: 4:17 PM EDT
15 minutes delayed
BioXcel Therapeutics (BTAI) ForecastNewsEarningsGuidanceDividendsAnalyst Ratings

Insider Trades

Short Interest

BioXcel Therapeutics (NASDAQ:BTAI) Stock, Insider Trading Activity

BioXcel Therapeutics: Insider buying and selling updated today.

Institutional Shares Held
7.053M
Institutional Percentage Held
19.0%
Jun 18, 2024Frank YoccaCHIEF SCIENTIFIC OFFICER711$1.28-$476.16SELL-OPTIONS5.57%13.474KJun 14 - Jun 17View
Jun 18, 2024Matthew T WileyCHIEF COMMERCIAL OFFICER506$1.26-$308.10SELL-OPTIONS16.91%3.498KJun 15 - Jun 17View
Jun 18, 2024Richard SteinhartCHIEF FINANCIAL OFFICER711$1.26-$469.54SELL-OPTIONS14.92%5.476KJun 14 - Jun 17View
Jun 18, 2024Javier RodriguezSEE REMARKS722$1.26-$456.02SELL-OPTIONS9.41%8.394KJun 14 - Jun 17View
Jun 18, 2024Vincent O'NeillSEE REMARKS366$1.28-$199.17SELL-OPTIONS11.59%3.524KJun 14 - Jun 17View
Jun 18, 2024Vimal MehtaCEO AND PRESIDENT3.975K$1.28-$2.74KSELL-OPTIONS0.05%7.73304MJun 14 - Jun 17View
Jun 06, 2024Vimal MehtaBioXcel Holdings IncBioXcel LLCCEO AND PRESIDENT-1.427494M$1.61-$405.14KSELL-15.66%7.687501MJun 04 - Jun 05View
Apr 08, 2024Vincent O'NeillSEE REMARKS2.606K$2.62-$432.48SELL-OPTIONS93.00%5.408KMar 14 - Apr 04View
Apr 08, 2024Vimal MehtaCEO AND PRESIDENT11.342K$2.62-$13.82KSELL-OPTIONS0.13%8.590314MMar 14 - Apr 04View
Apr 08, 2024Richard SteinhartCHIEF FINANCIAL OFFICER1.702K$2.63-$2.82KSELL-OPTIONS55.57%4.765KMar 14 - Apr 04View
Apr 08, 2024Matthew T WileyCHIEF COMMERCIAL OFFICER1.992K$2.64-$2.66KSELL-OPTIONS199.20%2.992KMar 15 - Apr 04View
Apr 08, 2024Javier RodriguezSEE REMARKS1.759K$2.64-$2.67KSELL-OPTIONS29.75%7.672KMar 14 - Apr 04View
Apr 08, 2024Frank YoccaCHIEF SCIENTIFIC OFFICER1.704K$2.63-$2.81KSELL-OPTIONS15.41%12.763KMar 14 - Apr 04View
Jun 16, 2023Vimal MehtaCEO AND PRESIDENT2.609K$10.64-$1.23MSELL-OPTIONS6.64%41.903KJun 14 - Jun 16View
May 24, 2023Vimal MehtaCEO AND PRESIDENT-6.5K$25.79-$167.64KSELL-14.19%39.294KMay 22View
May 16, 2023Richard SteinhartCHIEF FINANCIAL OFFICER0$27.17-$135.86KSELL-OPTIONS0.00%1.5KMay 14 - May 15View
May 16, 2023Javier RodriguezSEE REMARKS3.215K$27.32-$48.76KSELL-OPTIONS283.26%4.35KMay 14 - May 15View
Apr 10, 2023Krishnan NandabalanDIRECTOR0$8.87-$1.01MSELL-OPTIONS0.00%8.54675MApr 06View
Mar 22, 2023Vimal MehtaCEO AND PRESIDENT-4.5K$9.69-$1.20MSELL-20.09%17.894KMar 20 - Mar 21View
Mar 16, 2023Richard SteinhartCHIEF FINANCIAL OFFICER0$19.50-$40.64KSELL-OPTIONS0.00%1.5KMar 14 - Mar 15View
Mar 16, 2023Frank YoccaCHIEF SCIENTIFIC OFFICER1.099K$19.69-$19.40KSELL-OPTIONS13.09%9.496KMar 14 - Mar 15View
Mar 16, 2023Vincent O'NeillCHIEF MEDICAL OFFICER1.239K$19.70-$16.64KSELL-OPTIONS∞1.239KMar 14 - Mar 15View
Mar 16, 2023Javier RodriguezSEE REMARKS1.134K$19.63-$18.64KSELL-OPTIONS113400.00%1.135KMar 14 - Mar 15View
Jan 24, 2023Frank YoccaCHIEF SCIENTIFIC OFFICER-50K$30.00-$1.50MSELL-85.62%8.397KJan 20View
Jan 24, 2023Vincent O'NeillCHIEF MEDICAL OFFICER0$15.21-$879.21KSELL-OPTIONS0.00%0Jan 20View
Jan 06, 2023Krishnan NandabalanDIRECTOR0$11.21-$1.30MSELL-OPTIONS0.00%8.54675MJan 04 - Jan 05View
Dec 19, 2022Vimal MehtaCEO AND PRESIDENT0$10.05-$1.16MSELL-OPTIONS0.00%11.957KDec 15 - Dec 16View
Nov 14, 2022Krishnan NandabalanDIRECTOR0$7.71-$875.40KSELL-OPTIONS0.00%8.54675MNov 10 - Nov 11View
Jun 29, 2021Vimal MehtaCEO, PRESIDENT AND SECRETARY-473.25K$30.83-$14.59MSELL-5.24%8.556707MJun 25View
Jun 29, 2021Krishnan NandabalanDIRECTOR-473.25K$30.83-$14.59MSELL-5.25%8.54675MJun 25View
Jun 29, 2021BioXcel LLC10% OWNER-473.25K$30.83-$14.59MSELL-5.25%8.54675MJun 25View
Jun 29, 2021BioXcel Holdings Inc10% OWNER-473.25K$30.83-$14.59MSELL-5.25%8.54675MJun 25View
Mar 17, 2021Frank YoccaCHIEF SCIENTIFIC OFFICER-15K$48.50-$727.57KSELL-20.44%58.397KMar 15View
Feb 19, 2021Vincent O'NeillCHIEF MEDICAL OFFICER0$30.11-$1.27MSELL-OPTIONS0.00%0Feb 17View
Feb 18, 2021Frank YoccaCHIEF SCIENTIFIC OFFICER-15K$57.68-$865.15KSELL-16.97%73.397KFeb 16View
Feb 16, 2021Vimal MehtaCEO, PRESIDENT AND SECRETARY-78K$60.15-$4.84MDISPOSITION-49.37%80KMar 12 - Jul 24View
Feb 03, 2021Richard I SteinhartCHIEF FINANCIAL OFFICER0$26.85-$159.75KSELL-OPTIONS0.00%1.5KFeb 01View
Jan 27, 2021Frank YoccaCHIEF SCIENTIFIC OFFICER0$24.40-$719.66KSELL-OPTIONS0.00%88.397KJan 25View
Jan 21, 2021Vincent O'NeillCHIEF MEDICAL OFFICER0$24.94-$1.23MSELL-OPTIONS0.00%0Jan 19View
Dec 30, 2020Vincent O'Neill—0$25.93-$1.28MOPTION EXERCISE0.00%0Dec 28View
Aug 26, 2019Peter MuellerDIRECTOR1.554K$9.34$14.51KBUY0.93%168.32KAug 23View
Aug 23, 2019Peter MuellerDIRECTOR8.446K$8.74$73.84KBUY5.33%166.766KAug 21 - Aug 22View
Aug 19, 2019Vimal MehtaCEO, PRESIDENT AND SECRETARY974$8.89$8.66KBUY10.84%9.957KAug 16View
Aug 16, 2019Vimal MehtaCEO, PRESIDENT & SECRETARY2.983K$8.64$25.78KBUY49.72%8.983KAug 14 - Aug 15View
Aug 14, 2019Vimal MehtaCEO, PRESIDENT & SECRETARY1K$8.75$8.75KBUY20.00%6KAug 13View
Aug 14, 2019Frank YoccaCHIEF SCIENTIFIC OFFICER6.547K$8.67$56.76KBUY353.89%8.397KAug 13View

FAQ

Q

Is insider trading legal?

A
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
Q

What are some examples of market manipulation?

A
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.

Browse insider trades on all stocks.

People Also Watch